ERBB4 and neoplasm: The data shown thus far suggests that the tumor suppressor activity of the constitutively-active ErbB4 Q646C mutant is dependent on cleavage by gamma-secretase and on interactions of ErbB4 with steroid hormone receptors and Bcl family proteins.